SCHEMBL29318332

SCHEMBL29318332

c1ccc(-c2ccc(-c3nc(-c4ccc(-n5c6ccccc6c6ccc7c8ccccc8oc7c65)cc4)nc(-c4cccc(-c5ccccc5)c4)n3)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.35
TSHR P16473 3/20 0.35
PLA2G2A P14555 2/20 0.34
PLA2G4A P47712 2/20 0.34
ALOX5 P09917 1/20 0.34
KDM4E B2RXH2 4/20 0.33
ALDH1A1 P00352 4/20 0.33
LMNA P02545 4/20 0.33
HSD17B10 Q99714 2/20 0.33
POLB P06746 2/20 0.33
HPGD P15428 1/20 0.33
MAPK1 P28482 1/20 0.33
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
PLA2G10 O15496 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
USP2 O75604 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18505519 1.00 MAPT (0.35) MAPTTSHRPLA2G2APLA2G4AALOX5
SCHEMBL24218047 1.00 MAPT (0.35) MAPTTSHRPLA2G2APLA2G4AALOX5
SCHEMBL19474437 0.99 MAPT (0.36) MAPTTSHRPLA2G2APLA2G4AALOX5
SCHEMBL19474358 0.99 MAPT (0.36) MAPTTSHRPLA2G2APLA2G4AALOX5
SCHEMBL27442660 0.96 KDM4E (0.33) MAPTTSHRPLA2G2APLA2G4AKDM4E
SCHEMBL27442646 0.96 KDM4E (0.33) MAPTTSHRPLA2G2APLA2G4AKDM4E
SCHEMBL27442650 0.96 KDM4E (0.33) MAPTTSHRPLA2G2APLA2G4AKDM4E
SCHEMBL27442653 0.96 KDM4E (0.33) MAPTTSHRPLA2G2APLA2G4AKDM4E
SCHEMBL27442655 0.96 KDM4E (0.33) MAPTTSHRPLA2G2APLA2G4AKDM4E
SCHEMBL27442644 0.96 KDM4E (0.33) MAPTTSHRPLA2G2APLA2G4AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240244949-A1 ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING THE SAME LG DISPLAY CO., LTD. (KR) 2024-07-18 US disclosed
US-20240244949-A1 ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING THE SAME LG DISPLAY CO., LTD. (KR) 2024-07-18 US disclosed
US-20240244868-A1 ORGANIC LIGHT EMITTING DIODE COMPRISING ORGANOMETALLIC COMPOUND AND PLURALITY OF HOST MATERIALS LG DISPLAY CO., LTD. (KR) 2024-07-18 US disclosed
US-20240244868-A1 ORGANIC LIGHT EMITTING DIODE COMPRISING ORGANOMETALLIC COMPOUND AND PLURALITY OF HOST MATERIALS LG DISPLAY CO., LTD. (KR) 2024-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240244949-A1 ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING THE SAME EML4, OXA1L, TBL2 MAPT 642/4885TSHR 2974/4885PLA2G2A 4610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.